Prepsychotic Treatment for Schizophrenia: Preventive Medicine, Social Control, or Drug Marketing Strategy?

ISSN： 1523-150X

Source： Ethical Human Sciences and Services, Vol.1, Iss.2, 1999-01, pp. : 165-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the drug treatment of schizophrenia

By McCreadie Robin G.

Primary Care Psychiatry, Vol. 6, Iss. 1, 2000-03 ,pp. : 9-14

Informa Healthcare

Access to resources Recommend Favorite

Famotidine: a supplemental drug for the treatment of schizophrenia

By Dannon P. Lepkifker E. Iancu I. Ziv R. Horesh N. Kotler M.

European Psychiatry, Vol. 12, Iss. 5, 1997-01 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Glucose Metabolism in Relation to Schizophrenia and Antipsychotic Drug Treatment

By Dwyer D.S.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 2, 2001-06 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite

Keeping an open mind: Investigating options for treatment of the pre-psychotic phase

By YUNG ALISON MCGORRY PATRICK

Journal of Mental Health, Vol. 12, Iss. 4, 2003-08 ,pp. : 341-343

Informa Healthcare

Access to resources Recommend Favorite

Antipsychotic Drug Doses and Adjunctive Drugs in the Outpatient Treatment of Schizophrenia

By Galletly C.A.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 09, Iss. 2, 1997-06 ,pp. : 77-80

Springer Publishing Company

Access to resources Recommend Favorite